Business Context and Reporting Period
Company: CorVel Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: March 31, 2006
Business Overview: CorVel is an independent nationwide provider of medical cost containment and managed care services, primarily for workers' compensation, auto insurance, and group health policies. Services include automated medical fee auditing, preferred provider networks (PPO), utilization review, case management, and vocational rehabilitation. The company operates in one reportable segment: managed care.
Key Financial Metrics (Fiscal Year 2006)
| Metric | 2006 | 2005 (Restated) |
|---|---|---|
| Revenues | $266.5 million | $291.0 million |
| Cost of Revenues | $221.1 million | $246.3 million |
| Gross Profit | $45.4 million | $44.7 million |
| Gross Margin | 17.1% | 15.4% |
| Net Income | $9.8 million | $10.2 million |
| Diluted EPS | $1.00 | $0.97 |
| Cash and Equivalents | $14.2 million | $8.9 million |
| Operating Cash Flow | $28.7 million | $26.4 million |
| Total Debt | $0 | $0 |
| Working Capital | $34.6 million | $38.6 million |
Material Changes vs. Prior Period
- Revenue Decline: Revenues decreased 8.2% ($24.5 million) compared to fiscal 2005. The decline was driven by a reduction in patient management referrals due to a soft national labor market (specifically manufacturing) and increased employer use of early intervention services, which shortened claim durations. Network solutions revenue also declined due to lower demand for Independent Medical Examinations (IME) and MRI services.
- Cost Reductions: Cost of revenues decreased 10.2% ($25.3 million), outpacing the revenue decline. This was achieved through headcount reductions in the field and lower direct costs for MRI, IME, and prescription drug services.
- Operating Expenses: General and administrative expenses increased $1.4 million (to $29.6 million), primarily due to higher auditing and legal fees associated with Sarbanes-Oxley compliance.
- Profitability: Despite lower revenue, net income remained relatively stable ($9.8 million vs. $10.2 million) due to effective cost management. Gross margin improved to 17.1% from 15.4%.
- Share Repurchases: The company spent $18.7 million to repurchase 835,339 shares of common stock during the fiscal year, completing the 7.1 million shares authorized under the 1996 plan.
Guidance, Outlook, Risks, and Unusual Items
Internal Control Material Weaknesses
The company reported material weaknesses in internal controls over financial reporting as of March 31, 2006. The independent auditor issued an adverse opinion on the effectiveness of internal controls. Key deficiencies included:
- Inadequate accounting staff and lack of segregation of duties.
- Deficiencies in revenue recognition, accounts payable, fixed asset accounting, and payroll processing.
- Lack of effective anti-fraud controls and monitoring.
- These weaknesses led to a restatement of prior year financial statements (2004 and 2005) regarding lease accounting, though the impact on net income was deemed immaterial.
Outlook and Risks
- Market Conditions: Management cites a challenging environment with flat-to-declining workers' compensation markets, price competition, and potential legislative changes that could reduce demand for cost containment services.
- Accounting Changes: The company expects to adopt SFAS 123R (Share-Based Payment) in fiscal 2007, which will result in approximately $900,000 of additional non-cash compensation expense.
- Technology Investment: Continued investment in MedCheck software and data warehouse capabilities to improve efficiency and savings for clients.
Investor Verification Checklist
- Internal Control Remediation: Verify the specific steps taken to remediate the material weaknesses identified in the 2006 audit and the timeline for achieving effective controls.
- Revenue Trends: Monitor quarterly sequential revenue growth to confirm if the decline in patient management referrals has stabilized.
- Restatement Impact: Review the details of the lease accounting restatement to ensure no further adjustments are required for future periods.
- Stock Repurchase Program: Confirm the status of the new 1 million share repurchase authorization approved in June 2006.
- Regulatory Environment: Assess the impact of state-specific workers' compensation legislation (e.g., California's SB 899) on future service demand.